Details for New Drug Application (NDA): 050705
✉ Email this page to a colleague
The generic ingredient in RIFATER is isoniazid; pyrazinamide; rifampin. There are five drug master file entries for this compound. Additional details are available on the isoniazid; pyrazinamide; rifampin profile page.
Summary for 050705
Tradename: | RIFATER |
Applicant: | Sanofi Aventis Us |
Ingredient: | isoniazid; pyrazinamide; rifampin |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG;300MG;120MG | ||||
Approval Date: | May 31, 1994 | TE: | RLD: | Yes |
Complete Access Available with Subscription